vs

Side-by-side financial comparison of Dexcom (DXCM) and Helmerich & Payne, Inc. (HP). Click either name above to swap in a different company.

Dexcom is the larger business by last-quarter revenue ($1.3B vs $981.1M, roughly 1.3× Helmerich & Payne, Inc.). Dexcom runs the higher net margin — 21.2% vs -9.9%, a 31.1% gap on every dollar of revenue. On growth, Helmerich & Payne, Inc. posted the faster year-over-year revenue change (45.4% vs 21.6%). Over the past eight quarters, Helmerich & Payne, Inc.'s revenue compounded faster (19.7% CAGR vs 12.0%).

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

Helmerich & Payne, Inc. is an American petroleum contract drilling company engaged in oil and gas well drilling and related services for exploration and production companies headquartered in Tulsa, Oklahoma, with operations throughout the world. Their FlexRigs, introduced in 1998, have been used extensively in drilling unconventional shale formations, such as the Bakken formation in North Dakota and the Permian Basin and Eagle Ford formation in Texas. H&P is the largest on-shore driller in th...

DXCM vs HP — Head-to-Head

Bigger by revenue
DXCM
DXCM
1.3× larger
DXCM
$1.3B
$981.1M
HP
Growing faster (revenue YoY)
HP
HP
+23.9% gap
HP
45.4%
21.6%
DXCM
Higher net margin
DXCM
DXCM
31.1% more per $
DXCM
21.2%
-9.9%
HP
Faster 2-yr revenue CAGR
HP
HP
Annualised
HP
19.7%
12.0%
DXCM

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
DXCM
DXCM
HP
HP
Revenue
$1.3B
$981.1M
Net Profit
$267.3M
$-96.7M
Gross Margin
62.9%
Operating Margin
25.6%
-6.1%
Net Margin
21.2%
-9.9%
Revenue YoY
21.6%
45.4%
Net Profit YoY
153.6%
-276.6%
EPS (diluted)
$0.67
$-0.98

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DXCM
DXCM
HP
HP
Q1 26
$1.3B
Q4 25
$1.3B
$981.1M
Q3 25
$1.2B
$953.8M
Q2 25
$1.2B
$1.0B
Q1 25
$1.0B
$1.0B
Q4 24
$1.1B
$674.6M
Q3 24
$994.2M
$691.3M
Q2 24
$1.0B
$695.1M
Net Profit
DXCM
DXCM
HP
HP
Q1 26
$267.3M
Q4 25
$267.3M
$-96.7M
Q3 25
$283.8M
$-57.4M
Q2 25
$179.8M
$-162.8M
Q1 25
$105.4M
$1.7M
Q4 24
$151.7M
$54.8M
Q3 24
$134.6M
$75.5M
Q2 24
$143.5M
$88.7M
Gross Margin
DXCM
DXCM
HP
HP
Q1 26
62.9%
Q4 25
62.9%
Q3 25
60.5%
Q2 25
59.5%
Q1 25
56.9%
Q4 24
58.9%
Q3 24
59.7%
Q2 24
62.4%
Operating Margin
DXCM
DXCM
HP
HP
Q1 26
25.6%
Q4 25
25.6%
-6.1%
Q3 25
20.1%
-0.1%
Q2 25
18.4%
-12.4%
Q1 25
12.9%
4.2%
Q4 24
17.0%
13.3%
Q3 24
15.3%
15.4%
Q2 24
15.7%
16.0%
Net Margin
DXCM
DXCM
HP
HP
Q1 26
21.2%
Q4 25
21.2%
-9.9%
Q3 25
23.5%
-6.0%
Q2 25
15.5%
-15.7%
Q1 25
10.2%
0.2%
Q4 24
13.6%
8.1%
Q3 24
13.5%
10.9%
Q2 24
14.3%
12.8%
EPS (diluted)
DXCM
DXCM
HP
HP
Q1 26
$0.67
Q4 25
$0.67
$-0.98
Q3 25
$0.70
$-0.57
Q2 25
$0.45
$-1.64
Q1 25
$0.27
$0.01
Q4 24
$0.37
$0.54
Q3 24
$0.34
$0.77
Q2 24
$0.35
$0.88

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DXCM
DXCM
HP
HP
Cash + ST InvestmentsLiquidity on hand
$917.7M
$269.0M
Total DebtLower is stronger
$2.0B
Stockholders' EquityBook value
$2.7B
$2.7B
Total Assets
$6.3B
$6.5B
Debt / EquityLower = less leverage
0.75×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DXCM
DXCM
HP
HP
Q1 26
$917.7M
Q4 25
$917.7M
$269.0M
Q3 25
$1.8B
$218.3M
Q2 25
$1.2B
$187.4M
Q1 25
$904.9M
$195.6M
Q4 24
$606.1M
$526.5M
Q3 24
$621.2M
$510.3M
Q2 24
$939.2M
$289.7M
Total Debt
DXCM
DXCM
HP
HP
Q1 26
Q4 25
$2.0B
Q3 25
$2.1B
Q2 25
$2.2B
Q1 25
$2.2B
Q4 24
Q3 24
$1.8B
Q2 24
Stockholders' Equity
DXCM
DXCM
HP
HP
Q1 26
$2.7B
Q4 25
$2.7B
$2.7B
Q3 25
$2.7B
$2.8B
Q2 25
$2.6B
$2.9B
Q1 25
$2.3B
$3.1B
Q4 24
$2.1B
$2.9B
Q3 24
$2.0B
$2.9B
Q2 24
$2.4B
$2.9B
Total Assets
DXCM
DXCM
HP
HP
Q1 26
$6.3B
Q4 25
$6.3B
$6.5B
Q3 25
$7.5B
$6.7B
Q2 25
$7.3B
$6.9B
Q1 25
$6.8B
$7.2B
Q4 24
$6.5B
$5.8B
Q3 24
$6.4B
$5.8B
Q2 24
$6.8B
$4.5B
Debt / Equity
DXCM
DXCM
HP
HP
Q1 26
Q4 25
0.75×
Q3 25
0.73×
Q2 25
0.76×
Q1 25
0.73×
Q4 24
Q3 24
0.61×
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DXCM
DXCM
HP
HP
Operating Cash FlowLast quarter
$182.4M
Free Cash FlowOCF − Capex
$114.9M
FCF MarginFCF / Revenue
11.7%
Capex IntensityCapex / Revenue
6.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$179.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DXCM
DXCM
HP
HP
Q1 26
Q4 25
$294.0M
$182.4M
Q3 25
$659.9M
$206.9M
Q2 25
$303.0M
$121.6M
Q1 25
$183.8M
$56.0M
Q4 24
$301.4M
$158.4M
Q3 24
$199.5M
$168.8M
Q2 24
$279.4M
$197.4M
Free Cash Flow
DXCM
DXCM
HP
HP
Q1 26
Q4 25
$192.1M
$114.9M
Q3 25
$579.4M
$142.8M
Q2 25
$208.9M
$24.6M
Q1 25
$96.8M
$-102.7M
Q4 24
$176.8M
$51.9M
Q3 24
$88.3M
$62.8M
Q2 24
$213.3M
$63.0M
FCF Margin
DXCM
DXCM
HP
HP
Q1 26
Q4 25
15.3%
11.7%
Q3 25
47.9%
15.0%
Q2 25
18.1%
2.4%
Q1 25
9.3%
-10.1%
Q4 24
15.9%
7.7%
Q3 24
8.9%
9.1%
Q2 24
21.2%
9.1%
Capex Intensity
DXCM
DXCM
HP
HP
Q1 26
Q4 25
8.1%
6.9%
Q3 25
6.7%
6.7%
Q2 25
8.1%
9.3%
Q1 25
8.4%
15.7%
Q4 24
11.2%
15.8%
Q3 24
11.2%
15.3%
Q2 24
6.6%
19.3%
Cash Conversion
DXCM
DXCM
HP
HP
Q1 26
Q4 25
1.10×
Q3 25
2.33×
Q2 25
1.69×
Q1 25
1.74×
33.89×
Q4 24
1.99×
2.89×
Q3 24
1.48×
2.24×
Q2 24
1.95×
2.23×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DXCM
DXCM

Segment breakdown not available.

HP
HP

North America Solutions$563.6M57%
International Solutions Segment$229.3M23%
Offshore Solutions$188.3M19%

Related Comparisons